Ultragenyx Pharmaceutical Inc (RARE)

HEALTH CARE: BIOTECHNOLOGY & LIFE SCIENCES
SIC: PHARMACEUTICAL PREPARATIONS

60 LEVERONI COURT NOVATO, CA 94949

Ultragenyx Pharmaceutical Inc. provides biotechnology services. The company develops therapeutics and sialic acid for treating metabolic, body myopathy, glucuronidase, and rare genetic diseases. Ultragenyx Pharmaceutical conducts its business in the United States.

Data as of 2021-04-11 07:35:38 -0400
Market Cap6.928 Billion Shares Outstanding66.949 Million Avg 30-day Volume466.451 Thousand
P/E Ratio-37.13382 Dividend Yield EPS-3.07
Price/Sales25.56 Debt to Equity1.52 EBITDA-317.855 Million
Price to Book Value6.0 Forward PE-20.71 Enterprise Value5.728 Billion
Total Cash1.202 Billion Current Debt189.609 Million Gross Profit264.901 Million
BETA1.20418 52-week High/Low179.65 / 51.73 Next Earnings Date2021-05-06 Price to Cash FLow (P/CF) -284.9339
Data provided by IEX Cloud

Are you looking for these stocks instead?

View SEC Filings from RARE instead.
Q4 2020 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 1 0 0 (0.0%) 0 (0.0%)
Funds Holding: 249 203 22.66% 72 (4.33%) 60 (3.74%) 20.0%
13F shares: 67.643 Million 62.734 Million 7.82% 12.332 Million 11.551 Million 6.77%
% Ownership 94.8284 18.6412 17.4595 6.77%
New Positions: 61 36 69.44% 19 10 90.0%
Increased Positions 95 82 15.85% 26 23 13.04%
Closed Positions 16 22 -27.27% 8 9 -11.11%
Reduced Positions 69 63 9.52% 23 26 -11.54%
Total Calls 566.808 Thousand 71.702 Thousand 690.51% 95.4 Thousand 37.1 Thousand 157.14%
Total Puts 131.4 Thousand 35.5 Thousand 270.14% 18.1 Thousand 29.5 Thousand -38.64%
PUT/CALL Ratio 0.23 0.5 -54.0% 0.19 0.8 -76.25%
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding RARE (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding RARE BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

67.9 Thousand total shares from 11 transactions

Exercise Derivative Conversion (M)

7.5 Thousand total shares from 1 transactions

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

HUIZENGA THEODORE ALAN SVP, CONTROLLER AND PAO

  • Officer
13,544 2021-03-08 10

KASSBERG THOMAS RICHARD CBO & EVP

  • Officer
229,795 2021-03-01 4

KAKKIS EMIL D PRESIDENT & CEO

  • Officer
  • Director
2,921,793 2021-03-01 9

HUANG DENNIS KARL EVP & CHIEF TECH OPS OFFICER

  • Officer
96,596 2021-03-01 4

PINION JOHN RICHARD SEE REMARKS

  • Officer
61,237 2021-03-01 5

PARSCHAUER KARAH HERDMAN EVP AND GENERAL COUNSEL

  • Officer
41,227 2021-03-01 11

BEDROSIAN CAMILLE L EVP AND CHIEF MEDICAL OFFICER

  • Officer
50,139 2021-03-01 5

HARRIS ERIK EVP & CHIEF COMMERCIAL OFFICER

  • Officer
67,333 2021-03-01 6

DIER MARDI CFO & EXECUTIVE VICE PRESIDENT

  • Officer
56,500 2021-03-01 3

ALISKI WILLIAM

  • Director
145,510 2021-02-19 6

SHARP SHALINI EVP, FINANCE

  • Officer
97,812 2020-10-14 6

SIEGALL CLAY B

  • Director
2,550 2020-08-07 2

FUST MATTHEW K

  • Director
13,550 2020-07-06 5

NARACHI MICHAEL

  • Director
12,300 2020-06-26 1

WELCH DANIEL G

  • Director
12,300 2020-06-26 1

EKMAN LARS

  • Director
12,300 2020-06-26 1

DUNSIRE DEBORAH

  • Director
10,425 2020-06-26 1

SULIMAN SHEHNAAZ

  • Director
5,550 2020-06-26 1

HOGENHUIS WLADIMIR CHIEF OPERATING OFFICER

  • Officer
18,703 2019-10-04 0

DALLAS JAYSON DONALD ALEXANDER EVP & CHIEF COMMERCIAL OFFICER

  • Officer
23,830 2018-06-01 0

AGARWAL SUNIL CHIEF MEDICAL OFFICER

9,136 2016-08-19 0

FMR LLC

  • SEE REMARK 1.
No longer subject to file 2014-08-01 0

TPG GROUP HOLDINGS (SBS) ADVISORS, INC.

BONDERMAN DAVID

COULTER JAMES G

  • FORMER 10% OWNER (2)(3)(4)(5)FORMER 10% OWNER (2)(3)(4)(5)FORMER 10% OWNER (2)(3)(4)(5)
No longer subject to file 2014-07-14 0

NADAV ERAN

  • Director
0 2014-07-10 0

STEEN MARTEN

  • Director
0 2014-01-30 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

HUIZENGA THEODORE ALAN - Officer SVP, CONTROLLER AND PAO

2021-03-09 12:37:46 -0500 2021-03-08 S 3,000 $120.69 d 13,544 direct -3.4294 4.0573 4.0654 5 -3.4294 2

HARRIS ERIK - Officer EVP & CHIEF COMMERCIAL OFFICER

2021-03-03 20:42:01 -0500 2021-03-02 S 707 $138.16 d 27,813 direct yes -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

PINION JOHN RICHARD - Officer SEE REMARKS

2021-03-03 20:48:06 -0500 2021-03-01 A 4,636 a 56,435 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

KAKKIS EMIL D - Director - Officer PRESIDENT & CEO by emil kakkis and jenny soriano living trust, dated june 18, 2009

2021-03-03 20:36:55 -0500 2021-03-01 S 30,000 $141.80 d 2,289,741 indirect yes -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

KAKKIS EMIL D - Director - Officer PRESIDENT & CEO

2021-03-03 20:36:55 -0500 2021-03-01 A 18,000 a 596,941 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

KASSBERG THOMAS RICHARD - Officer CBO & EVP

2021-03-03 20:55:51 -0500 2021-03-01 A 4,636 a 111,614 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

HUANG DENNIS KARL - Officer EVP & CHIEF TECH OPS OFFICER

2021-03-03 20:39:51 -0500 2021-03-01 S 4,255 $138.18 d 40,761 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

HARRIS ERIK - Officer EVP & CHIEF COMMERCIAL OFFICER

2021-03-03 20:42:01 -0500 2021-03-01 A 11,000 a 11,000 direct

HARRIS ERIK - Officer EVP & CHIEF COMMERCIAL OFFICER

2021-03-03 20:42:01 -0500 2021-03-01 A 4,636 a 30,990 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

HUIZENGA THEODORE ALAN - Officer SVP, CONTROLLER AND PAO

2021-03-03 20:43:11 -0500 2021-03-01 S 732 $138.17 d 16,544 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

DIER MARDI - Officer CFO & EXECUTIVE VICE PRESIDENT

2021-03-03 20:38:52 -0500 2021-03-01 A 5,500 a 45,500 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

PARSCHAUER KARAH HERDMAN - Officer EVP AND GENERAL COUNSEL

2021-03-03 20:47:24 -0500 2021-03-01 S 3,970 $138.17 d 30,227 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

BEDROSIAN CAMILLE L - Officer EVP AND CHIEF MEDICAL OFFICER

2021-03-03 20:37:53 -0500 2021-03-01 A 4,636 a 43,682 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

PINION JOHN RICHARD - Officer SEE REMARKS

2021-03-03 20:48:06 -0500 2021-03-01 A 11,000 a 11,000 direct

PINION JOHN RICHARD - Officer SEE REMARKS

2021-03-03 20:48:06 -0500 2021-03-01 A 5,500 a 51,799 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

KAKKIS EMIL D - Director - Officer PRESIDENT & CEO

2021-03-03 20:36:55 -0500 2021-03-01 F 16,342 $142.47 d 596,052 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

KASSBERG THOMAS RICHARD - Officer CBO & EVP

2021-03-03 20:55:51 -0500 2021-03-01 A 11,000 a 11,000 direct

KASSBERG THOMAS RICHARD - Officer CBO & EVP

2021-03-03 20:55:51 -0500 2021-03-01 A 5,500 a 106,978 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

HUANG DENNIS KARL - Officer EVP & CHIEF TECH OPS OFFICER

2021-03-03 20:39:51 -0500 2021-03-01 A 4,636 a 44,835 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

HARRIS ERIK - Officer EVP & CHIEF COMMERCIAL OFFICER

2021-03-03 20:42:01 -0500 2021-03-01 A 5,500 a 26,354 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

HUIZENGA THEODORE ALAN - Officer SVP, CONTROLLER AND PAO

2021-03-03 20:43:11 -0500 2021-03-01 A 1,560 a 17,276 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

BEDROSIAN CAMILLE L - Officer EVP AND CHIEF MEDICAL OFFICER

2021-03-03 20:37:53 -0500 2021-03-01 A 11,000 a 11,000 direct

PARSCHAUER KARAH HERDMAN - Officer EVP AND GENERAL COUNSEL

2021-03-03 20:47:24 -0500 2021-03-01 A 4,636 a 34,197 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

BEDROSIAN CAMILLE L - Officer EVP AND CHIEF MEDICAL OFFICER

2021-03-03 20:37:53 -0500 2021-03-01 A 5,500 a 39,046 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

PINION JOHN RICHARD - Officer SEE REMARKS

2021-03-03 20:48:06 -0500 2021-03-01 S 6,198 $138.17 d 50,237 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

KAKKIS EMIL D - Director - Officer PRESIDENT & CEO

2021-03-03 20:36:55 -0500 2021-03-01 A 36,000 a 36,000 direct

KAKKIS EMIL D - Director - Officer PRESIDENT & CEO

2021-03-03 20:36:55 -0500 2021-03-01 A 15,453 a 612,394 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

KASSBERG THOMAS RICHARD - Officer CBO & EVP

2021-03-03 20:55:51 -0500 2021-03-01 S 4,572 $138.17 d 107,181 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

HUANG DENNIS KARL - Officer EVP & CHIEF TECH OPS OFFICER

2021-03-03 20:39:51 -0500 2021-03-01 A 11,000 a 11,000 direct

HUANG DENNIS KARL - Officer EVP & CHIEF TECH OPS OFFICER

2021-03-03 20:39:51 -0500 2021-03-01 A 5,500 a 40,199 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

HARRIS ERIK - Officer EVP & CHIEF COMMERCIAL OFFICER

2021-03-03 20:42:01 -0500 2021-03-01 S 2,470 $138.17 d 28,520 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

HUIZENGA THEODORE ALAN - Officer SVP, CONTROLLER AND PAO

2021-03-03 20:43:11 -0500 2021-03-01 A 4,655 a 4,655 direct

DIER MARDI - Officer CFO & EXECUTIVE VICE PRESIDENT

2021-03-03 20:38:52 -0500 2021-03-01 A 11,000 a 11,000 direct

PARSCHAUER KARAH HERDMAN - Officer EVP AND GENERAL COUNSEL

2021-03-03 20:47:24 -0500 2021-03-01 A 11,000 a 11,000 direct

BEDROSIAN CAMILLE L - Officer EVP AND CHIEF MEDICAL OFFICER

2021-03-03 20:37:53 -0500 2021-03-01 S 4,543 $138.18 d 39,139 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

PARSCHAUER KARAH HERDMAN - Officer EVP AND GENERAL COUNSEL

2021-03-03 20:47:24 -0500 2021-03-01 A 5,500 a 29,561 direct -0.1096 6.9291 -8.3537 8.9691 8 -15.2575 27

ALISKI WILLIAM - Director

2021-02-23 14:30:24 -0500 2021-02-23 G 1,000 d 64,704 direct 1.79 -0.2068 -24.9251 1.79 2 -24.9251 31

ALISKI WILLIAM - Director

2021-02-23 14:30:24 -0500 2021-02-19 M 7,500 $97.85 a 73,204 direct 1.79 -0.2068 -24.9251 1.79 2 -24.9251 31

ALISKI WILLIAM - Director

2021-02-23 14:30:24 -0500 2021-02-19 S 7,500 $149.01 d 65,704 direct 1.79 -0.2068 -24.9251 1.79 2 -24.9251 31

ALISKI WILLIAM - Director

2021-02-23 14:30:24 -0500 2021-02-19 M 7,500 d 0 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-04-19 16:45:02 UTC -0.19 0.25 1100000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-04-19 16:15:03 UTC -0.19 0.25 1100000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-04-19 15:45:03 UTC -0.19 0.25 1100000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-04-19 15:15:03 UTC -0.19 0.25 1100000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-04-19 14:45:03 UTC -0.19 0.25 1100000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-04-19 14:15:03 UTC -0.19 0.25 1100000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-04-19 13:45:02 UTC -0.19 0.25 1100000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-04-19 13:15:02 UTC -0.19 0.25 1100000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-04-19 12:45:03 UTC -0.19 0.25 1100000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-04-16 22:15:03 UTC -0.19 0.25 1100000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-04-16 21:45:03 UTC -0.19 0.25 1100000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-04-16 21:15:02 UTC -0.19 0.25 1100000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-04-16 20:45:03 UTC -0.19 0.25 1100000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-04-16 20:15:04 UTC -0.19 0.25 1100000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-04-16 19:45:03 UTC -0.19 0.25 1100000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-04-16 19:15:03 UTC -0.19 0.25 1100000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-04-16 18:45:03 UTC -0.19 0.25 1100000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-04-16 18:15:03 UTC -0.19 0.25 1100000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-04-16 17:45:03 UTC -0.19 0.25 1100000
ULTRAGENYX PHARMACEUTICAL IN RARE 2021-04-16 17:15:03 UTC -0.19 0.25 1100000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin
American Century Quantitative Equity Funds, Inc.- AC Alternatives Disciplined Long Short Fund RARE -1795.0 shares, $-76664.45 2019-12-31 N-PORT
AGF Investments Trust- AGFIQ U.S. Market Neutral Value Fund RARE -36.0 shares, $-2958.84 2020-09-30 N-PORT
FundVantage Trust- Gotham Hedged Plus Fund RARE -66.0 shares, $-9136.38 2020-12-31 N-PORT
FundVantage Trust- Gotham Defensive Long Fund RARE -94.0 shares, $-4176.42 2020-03-31 N-PORT
INVESTMENT MANAGERS SERIES TRUST- AAM HIMCO Global Enhanced Dividend Fund RARE -1228.0 shares, $-169992.04 2020-12-31 N-PORT
FundVantage Trust- Gotham Index Plus All-Cap Fund RARE -36.0 shares, $-1599.48 2020-03-31 N-PORT

Elevate your investments